Riskpilot← Back to searchSign inGet full accessLevad Fysiotherapi AB
ABActiveOrg 5565997318Lundsuddevägen 6Physiotherapy activities · NACE 8695Est. 20001-4 employees
Revenue 2025
SEK 105K
-63% vs 2024
EBITDA margin
-216.1%
-1794% vs 2024
Equity ratio
48.5%
Financial strength
Net profit 2025
SEK 1K
+114% vs 2024
| Revenue | SEK 105K | -63% |
| EBITDA | SEK -227K | -1794% |
| Net profit | SEK 1K | +114% |
| Total assets | SEK 685K | -49% |
| Equity | SEK 332K | +0% |
| Employees | — | — |
Legal name
Levad Fysiotherapi AB
Org number
5565997318
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
1 november 2000
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva fysioterapi och rehabilitering av människor och djur, utbildning, föredrag och föreläsningar inom OMT- ortopedisk manuell terapi såsom massage, kiropraktik och naprapati, samt därmed förenlig verksamhet.
Address
Lundsuddevägen 6
Phone
+46706654568
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 362 | 2 266 | 1 303 | 280 | 105 |
| Staff expenses | — | −1 175 | −1 565 | −356 | −42 |
| EBITDA | 172 | 403 | −1 057 | 13 | −227 |
| Depreciation & amort. | −35 | −172 | −184 | −173 | −170 |
| EBIT | 137 | 230 | −1 242 | −160 | −397 |
| Net financials | −1 | −12 | −23 | −20 | 2 |
| Profit before tax | 101 | 38 | 4 | 7 | 2 |
| Tax | −23 | −9 | −2 | −16 | −1 |
| Net profit | 78 | 29 | 1 | −9 | 1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 142 | 1 679 | 2 005 | 1 356 | 685 |
| Equity | 310 | 339 | 340 | 331 | 332 |
| Long-term debt | 0 | 619 | 536 | 317 | 0 |
| Short-term debt | 645 | 534 | 942 | 709 | 353 |
| Total debt | 645 | 1 153 | 1 478 | 1 026 | 353 |
EBITDA margin
-216.1%
This company
15.8%
Market median
-1468% vs market
20212025
Equity ratio
48.5%
This company
38.2%
Market median
+27% vs market
20212025
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20212025
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Audit | 2021 – 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Levad Fysiotherapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristina Astrid Maria Halvdansson | Audit | 0 companies |
| Jan-Olof Oveby | Deputy Board Member | 0 companies |
| Birthe Katarina Vogelius | Board of Directors | 0 companies |